Home Applications 208562 Application 208562
Type NDA
Sponsor XELLIA PHARMS APS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 VORICONAZOLE VORICONAZOLE POWDER;INTRAVENOUS 200MG/VIAL No No 002 VORICONAZOLE VORICONAZOLE INJECTABLE;INJECTION 200MG Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N208562-001 VORICONAZOLE VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N208562-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N208562-001 VORICONAZOLE 200MG/VIAL INJECTABLE / INTRAVENOUS AP 2017-03-09 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N208562-001 VORICONAZOLE 200MG/VIAL POWDER / INTRAVENOUS AP 2017-03-09 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 7 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 39822-1077 Voriconazole Voriconazole X-GEN Pharmaceuticals, Inc. NDA Current 39822-1077 Voriconazole voriconazole X-Gen Pharmaceuticals Inc NDA Current 39822-1077 Voriconazole voriconazole XGen Pharmaceuticals DJB, Inc. NDA Current 39822-1077 Voriconazole Voriconazole XGen Pharmaceuticals DJB, Inc. NDA Current 39822-1077 Voriconazole Voriconazole XGen Pharmaceuticals DJB, Inc. NDA Current 70594-067 Voriconazole Voriconazole Xellia Pharmaceuticals USA LLC NDA Current 70594-067 Voriconazole Voriconazole Xellia Pharmaceuticals USA LLC NDA Current